small molecule inhibitor of histone methyltransferase DOT1L

small molecule inhibitor of histone methyltransferase DOT1L
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2013-08-15 00:00:00
Sponsor Epizyme Inc.;400 Technology Square, 4th Floor;Cambridge, Massachusetts, 02139
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia